Reversal of Moderate or Superficial Neuromuscular Blockade Induced by Cisatracurium

Clinical trial NCT04920682 · COMPLETED

Trial details

NCT number: NCT04920682
Sponsor: Pontificia Universidade Catolica de Sao Paulo
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Neostigmine Neuromuscular Blocking Agents Muscle Weakness

Start date: 2021-06-01
Primary completion: 2021-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.